| Size | Price | Stock | Qty |
|---|---|---|---|
| 10mg |
|
||
| 50mg |
|
||
| Other Sizes |
|
Purity: ≥98%
Ly93 (SMS2-IN-Ly93) is a novel, potent, selective and oral bioavailable sphingomyelin synthase 2 (SMS2) inhibitor with an IC50 of 91 nM, showing more than 1400-fold selectivity over sms1
| ln Vivo |
In C57BL/6J mice, Ly93 (100 mg/kg, ig once daily for seven days) dramatically decreased plasma SM levels [1]. Ly93 dose-dependently reduced the amount of macrophages in atherosclerotic lesions and the lesions themselves in the root and entire aorta in apolipoprotein E knockout mice [1].
|
|---|---|
| Animal Protocol |
Animal/Disease Models: C57BL/6J mouse[1].
Doses: 100 mg/kg. Route of Administration: IG (intragastric (po) (po)administration) one time/day for 7 days. Experimental Results: Plasma SM levels were Dramatically diminished compared to the vehicle group. Animal/Disease Models: ApoE KO mice (8 weeks old) [1]. Doses: 12.5 or 40 mg/kg. Route of Administration: IG (intragastric (po) (po)administration) one time/day. Experimental Results: There were no statistical changes in the plasma levels of ALT and AST in apoE KO mice compared with the control group. |
| References |
| Molecular Formula |
C21H20N2O2
|
|---|---|
| Molecular Weight |
332.395705223084
|
| Exact Mass |
332.152
|
| CAS # |
1883528-69-5
|
| PubChem CID |
118911741
|
| Appearance |
Off-white to light yellow solid powder
|
| LogP |
3.9
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
25
|
| Complexity |
415
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O(C1=CC=CC=C1C(NC1C=NC=CC=1)=O)CC1C=CC=CC=1CC
|
| InChi Key |
YRUSTWBJNUPPQI-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C21H20N2O2/c1-2-16-8-3-4-9-17(16)15-25-20-12-6-5-11-19(20)21(24)23-18-10-7-13-22-14-18/h3-14H,2,15H2,1H3,(H,23,24)
|
| Chemical Name |
2-[(2-ethylphenyl)methoxy]-N-pyridin-3-ylbenzamide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~250 mg/mL (~752.11 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.26 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (6.26 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.08 mg/mL (6.26 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0084 mL | 15.0421 mL | 30.0842 mL | |
| 5 mM | 0.6017 mL | 3.0084 mL | 6.0168 mL | |
| 10 mM | 0.3008 mL | 1.5042 mL | 3.0084 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
COA